• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶组织内阿米巴在通过胞饮作用获得人补体调节蛋白后,发展出对补体沉积和裂解的抗性。

Entamoeba histolytica Develops Resistance to Complement Deposition and Lysis after Acquisition of Human Complement-Regulatory Proteins through Trogocytosis.

机构信息

Department of Microbiology and Molecular Genetics, University of California, Davisgrid.27860.3b, Davis, California, USA.

出版信息

mBio. 2022 Apr 26;13(2):e0316321. doi: 10.1128/mbio.03163-21. Epub 2022 Mar 1.

DOI:10.1128/mbio.03163-21
PMID:35227072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8941920/
Abstract

Entamoeba histolytica is the cause of amoebiasis. The trophozoite (amoeba) form of this parasite is capable of invading the intestine and can disseminate through the bloodstream to other organs. The mechanisms that allow amoebae to evade complement deposition during dissemination have not been well characterized. We previously discovered a novel complement-evasion mechanism employed by E. histolytica. E. histolytica ingests small bites of living human cells in a process termed trogocytosis. We demonstrated that amoebae were protected from lysis by human serum following trogocytosis of human cells and that amoebae acquired and displayed human membrane proteins from the cells they ingested. Here, we aimed to define how amoebae are protected from complement lysis after performing trogocytosis. We found that amoebae were protected from complement lysis after ingestion of both human Jurkat T cells and red blood cells and that the level of protection correlated with the amount of material ingested. Trogocytosis of human cells led to a reduction in deposition of C3b on the surface of amoebae. We asked whether display of human complement regulators is involved in amoebic protection, and found that CD59 was displayed by amoebae after trogocytosis. Deletion of a single complement-regulatory protein, CD59 or CD46, from Jurkat cells was not sufficient to alter amoebic protection from lysis, suggesting that multiple, redundant complement regulators mediate amoebic protection. However, exogeneous expression of CD46 or CD55 in amoebae was sufficient to confer protection from lysis. These studies shed light on a novel strategy for immune evasion by a pathogen. Entamoeba histolytica is the cause of amoebiasis, a diarrheal disease of global importance. While infection is often asymptomatic, the trophozoite (amoeba) form of this parasite is capable of invading and ulcerating the intestine and can disseminate through the bloodstream to other organs. Understanding how E. histolytica evades the complement system during dissemination is of great interest. Here, we demonstrate for the first time that amoebae that have performed trogocytosis (nibbling of human cells) resist deposition of the complement protein C3b. Amoebae that have performed trogocytosis display the complement-regulatory protein CD59. Overall, our studies suggest that acquisition and display of multiple, redundant complement regulators is involved in amoebic protection from complement lysis. These findings shed light on a novel strategy for immune evasion by a pathogen. Since other parasites use trogocytosis for cell killing, our findings may apply to the pathogenesis of other infections.

摘要

溶组织内阿米巴是引起阿米巴病的原因。这种寄生虫的滋养体(变形虫)形式能够侵入肠道,并通过血液传播到其他器官。目前尚未很好地描述允许阿米巴在传播过程中逃避补体沉积的机制。我们之前发现了溶组织内阿米巴采用的一种新的补体逃避机制。溶组织内阿米巴在一个称为胞饮作用的过程中摄取小块活的人体细胞。我们证明,在吞噬了人体细胞后,阿米巴可以免受人血清的溶解,并且阿米巴从它们吞噬的细胞中获得并显示人体膜蛋白。在这里,我们旨在定义在进行胞饮作用后,阿米巴如何免受补体溶解。我们发现,在吞噬了人 Jurkat T 细胞和红细胞后,阿米巴免受补体溶解的保护,并且保护水平与摄入的物质量相关。吞噬人体细胞导致阿米巴表面 C3b 的沉积减少。我们询问显示人体补体调节剂是否参与阿米巴的保护作用,发现吞噬作用后阿米巴显示 CD59。从 Jurkat 细胞中删除单个补体调节蛋白 CD59 或 CD46 不足以改变阿米巴免受溶解的保护作用,这表明多种冗余的补体调节蛋白介导阿米巴的保护作用。然而,在阿米巴中表达外源性 CD46 或 CD55 足以赋予其对溶解的保护作用。这些研究揭示了病原体免疫逃避的一种新策略。

溶组织内阿米巴是引起阿米巴病的原因,这是一种具有全球重要性的腹泻病。虽然感染通常无症状,但这种寄生虫的滋养体(变形虫)形式能够侵入和溃疡肠道,并通过血液传播到其他器官。了解溶组织内阿米巴在传播过程中如何逃避补体系统非常重要。在这里,我们首次证明进行胞饮作用(吞噬人体细胞)的阿米巴抵抗补体蛋白 C3b 的沉积。进行了胞饮作用的阿米巴显示出补体调节蛋白 CD59。总的来说,我们的研究表明,获得和显示多种冗余的补体调节剂参与了阿米巴免受补体溶解的保护作用。这些发现揭示了病原体免疫逃避的一种新策略。由于其他寄生虫使用胞饮作用进行细胞杀伤,我们的发现可能适用于其他感染的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/179ae48bf91a/mbio.03163-21-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/54e637123924/mbio.03163-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/26132749ade7/mbio.03163-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/0be1dad2a1cc/mbio.03163-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/5f0a8e7c9e3c/mbio.03163-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/1791478e5290/mbio.03163-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/d2ff909dba9f/mbio.03163-21-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/12d2a190977f/mbio.03163-21-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/179ae48bf91a/mbio.03163-21-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/54e637123924/mbio.03163-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/26132749ade7/mbio.03163-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/0be1dad2a1cc/mbio.03163-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/5f0a8e7c9e3c/mbio.03163-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/1791478e5290/mbio.03163-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/d2ff909dba9f/mbio.03163-21-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/12d2a190977f/mbio.03163-21-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ad1/8941920/179ae48bf91a/mbio.03163-21-f008.jpg

相似文献

1
Entamoeba histolytica Develops Resistance to Complement Deposition and Lysis after Acquisition of Human Complement-Regulatory Proteins through Trogocytosis.溶组织内阿米巴在通过胞饮作用获得人补体调节蛋白后,发展出对补体沉积和裂解的抗性。
mBio. 2022 Apr 26;13(2):e0316321. doi: 10.1128/mbio.03163-21. Epub 2022 Mar 1.
2
Trogocytosis by Entamoeba histolytica Mediates Acquisition and Display of Human Cell Membrane Proteins and Evasion of Lysis by Human Serum.溶组织内阿米巴通过细胞胞饮作用获得并展示人细胞膜蛋白,从而逃避人血清的裂解作用。
mBio. 2019 Apr 30;10(2):e00068-19. doi: 10.1128/mBio.00068-19.
3
Chew on this: amoebic trogocytosis and host cell killing by Entamoeba histolytica.思考一下这个:溶组织内阿米巴的阿米巴噬菌作用与宿主细胞杀伤。
Trends Parasitol. 2015 Sep;31(9):442-52. doi: 10.1016/j.pt.2015.05.003. Epub 2015 Jun 9.
4
Direct and high-throughput assays for human cell killing through trogocytosis by Entamoeba histolytica.通过溶组织内阿米巴的 trogocytosis 对人细胞杀伤的直接和高通量检测。
Mol Biochem Parasitol. 2020 Sep;239:111301. doi: 10.1016/j.molbiopara.2020.111301. Epub 2020 Jul 17.
5
Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond.咬一口:溶组织内阿米巴及其他生物中的阿米巴噬菌作用
Curr Opin Microbiol. 2015 Dec;28:26-35. doi: 10.1016/j.mib.2015.07.009. Epub 2015 Aug 14.
6
Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion.溶组织内阿米巴的细胞胞饮作用有助于细胞杀伤和组织侵袭。
Nature. 2014 Apr 24;508(7497):526-30. doi: 10.1038/nature13242. Epub 2014 Apr 9.
7
Inhibition of Amebic Lysosomal Acidification Blocks Amebic Trogocytosis and Cell Killing.抑制阿米巴溶酶体酸化可阻断阿米巴细胞的互噬作用和细胞杀伤。
mBio. 2017 Aug 29;8(4):e01187-17. doi: 10.1128/mBio.01187-17.
8
Trogocytosis in Unicellular Eukaryotes.单细胞真核生物中的胞饮作用。
Cells. 2021 Nov 1;10(11):2975. doi: 10.3390/cells10112975.
9
Taxon-Specific Proteins of the Pathogenic Species and .致病种属的种属特异性蛋白和。
Front Cell Infect Microbiol. 2021 Mar 19;11:641472. doi: 10.3389/fcimb.2021.641472. eCollection 2021.
10
Amoebic PI3K and PKC is required for Jurkat T cell death induced by Entamoeba histolytica.溶组织内阿米巴诱导Jurkat T细胞死亡需要阿米巴的PI3K和PKC。
Korean J Parasitol. 2014 Aug;52(4):355-65. doi: 10.3347/kjp.2014.52.4.355. Epub 2014 Aug 29.

引用本文的文献

1
Exploring virulence and stress response in : insights from clinical strains.探索[具体研究对象]中的毒力和应激反应:来自临床菌株的见解
Microbiol Spectr. 2025 Jul;13(7):e0050625. doi: 10.1128/spectrum.00506-25. Epub 2025 Jun 9.
2
Characterization of Entamoeba fatty acid elongases; validation as targets and provision of promising leads for new drugs against amebiasis.肠贾第鞭毛虫脂肪酸延长酶的特性;作为靶标验证和提供针对阿米巴病的新药有希望的先导化合物。
PLoS Pathog. 2024 Aug 22;20(8):e1012435. doi: 10.1371/journal.ppat.1012435. eCollection 2024 Aug.
3
Microbial evasion of the complement system: a continuous and evolving story.

本文引用的文献

1
Growth and Genetic Manipulation of Entamoeba histolytica.溶组织内阿米巴的生长与基因操作
Curr Protoc. 2022 Jan;2(1):e327. doi: 10.1002/cpz1.327.
2
Biting Off What Can Be Chewed: Trogocytosis in Health, Infection, and Disease.咬下可嚼之物:健康、感染和疾病中的胞噬作用。
Infect Immun. 2020 Jun 22;88(7). doi: 10.1128/IAI.00930-19.
3
Trogocytosis by Entamoeba histolytica Mediates Acquisition and Display of Human Cell Membrane Proteins and Evasion of Lysis by Human Serum.溶组织内阿米巴通过细胞胞饮作用获得并展示人细胞膜蛋白,从而逃避人血清的裂解作用。
微生物逃避补体系统:一个持续不断的演变故事。
Front Immunol. 2024 Jan 4;14:1281096. doi: 10.3389/fimmu.2023.1281096. eCollection 2023.
4
Pilot Study on the Prevalence of in Austria-Detection of a New Genetic Variant.奥地利[疾病名称]患病率的初步研究——一种新基因变异体的检测。 (注:原文中“Pilot Study on the Prevalence of in Austria-Detection of a New Genetic Variant.” 中间“of”后面缺少具体疾病名称)
Microorganisms. 2023 Apr 22;11(5):1094. doi: 10.3390/microorganisms11051094.
5
Pathogenicity and virulence of , the agent of amoebiasis.致病力与毒力的 ,阿米巴病的病原体。
Virulence. 2023 Dec;14(1):2158656. doi: 10.1080/21505594.2022.2158656.
6
The Defensive Interactions of Prominent Infectious Protozoan Parasites: The Host's Complement System.主要传染性原生动物寄生虫的防御相互作用:宿主的补体系统。
Biomolecules. 2022 Oct 26;12(11):1564. doi: 10.3390/biom12111564.
7
CD55 Facilitates Immune Evasion by Borrelia crocidurae, an Agent of Relapsing Fever.伯氏疏螺旋体(Borrelia crocidurae)通过 CD55 促进免疫逃逸,伯氏疏螺旋体是回归热的病原体。
mBio. 2022 Oct 26;13(5):e0116122. doi: 10.1128/mbio.01161-22. Epub 2022 Aug 29.
8
Pleiotropic Roles of Cholesteryl Sulfate during Encystation: Involvement in Cell Rounding and Development of Membrane Impermeability.胆甾醇硫酸酯在包囊形成过程中的多效作用:参与细胞变圆和膜不透性的发展。
mSphere. 2022 Aug 31;7(4):e0029922. doi: 10.1128/msphere.00299-22. Epub 2022 Aug 9.
9
Signaling Role of NADPH Oxidases in ROS-Dependent Host Cell Death Induced by Pathogenic Entamoeba histolytica.NADPH 氧化酶在致病性溶组织内阿米巴诱导的 ROS 依赖性宿主细胞死亡中的信号作用。
Korean J Parasitol. 2022 Jun;60(3):155-161. doi: 10.3347/kjp.2022.60.3.155. Epub 2022 Jun 30.
mBio. 2019 Apr 30;10(2):e00068-19. doi: 10.1128/mBio.00068-19.
4
CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.CRISPR/Cas9技术构建的人CD46、CD55和CD59基因敲除细胞系作为补体研究工具
J Immunol Methods. 2018 May;456:15-22. doi: 10.1016/j.jim.2018.02.004. Epub 2018 Feb 12.
5
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
6
Role of the Gut Microbiota of Children in Diarrhea Due to the Protozoan Parasite Entamoeba histolytica.儿童肠道微生物群在原生动物寄生虫溶组织内阿米巴所致腹泻中的作用。
J Infect Dis. 2016 May 15;213(10):1579-85. doi: 10.1093/infdis/jiv772. Epub 2015 Dec 27.
7
Complement regulator CD46: genetic variants and disease associations.补体调节蛋白CD46:基因变异与疾病关联
Hum Genomics. 2015 Jun 10;9(1):7. doi: 10.1186/s40246-015-0029-z.
8
Seroepidemiology of Entamoeba histolytica Infection in General Population in Rural Durango, Mexico.墨西哥杜兰戈州农村普通人群中溶组织内阿米巴感染的血清流行病学
J Clin Med Res. 2015 Jun;7(6):435-9. doi: 10.14740/jocmr2131w. Epub 2015 Apr 8.
9
Trogocytosis by Entamoeba histolytica contributes to cell killing and tissue invasion.溶组织内阿米巴的细胞胞饮作用有助于细胞杀伤和组织侵袭。
Nature. 2014 Apr 24;508(7497):526-30. doi: 10.1038/nature13242. Epub 2014 Apr 9.
10
Amoebic dysentery.阿米巴痢疾
BMJ Clin Evid. 2013 Aug 30;2013:0918.